Bluejay Diagnostics, Inc.
BJDX
$1.95
$0.063.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.15% | -7.80% | 20.96% | 19.93% | 37.81% |
| Total Depreciation and Amortization | 30.13% | -41.04% | -28.49% | -4.42% | -33.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6,000.00% | 545.61% | -100.35% | -89.08% | 99.30% |
| Change in Net Operating Assets | -40.74% | 123.16% | -169.72% | 1,761.54% | 89.03% |
| Cash from Operations | -0.25% | 36.89% | -7.27% | 48.48% | 47.75% |
| Capital Expenditure | -15,690.91% | -- | -- | -- | 98.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -15,690.91% | -- | -- | -- | 98.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 99.33% | 99.95% | -11.11% | 16.67% |
| Issuance of Common Stock | -- | -100.00% | -55.11% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 59.00% | -- | 100.00% |
| Cash from Financing | 285,576.92% | 99.32% | -55.41% | -100.04% | 58.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 243.25% | 40.90% | -75.41% | -361.94% | 49.32% |